COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1Life Healthcare, Inc. | Common | 68269G107 | 1,222 | 31,266 | SH | | SOLE | | 31,266 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 89,120 | 743,657 | SH | | SOLE | | 743,657 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 67,070 | 619,759 | SH | | SOLE | | 619,759 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 8,560 | 331,789 | SH | | SOLE | | 331,789 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 13,597 | 337,722 | SH | | SOLE | | 337,722 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 3,937 | 37,640 | SH | | SOLE | | 37,640 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 2,278 | 288,019 | SH | | SOLE | | 288,019 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 6,678 | 52,525 | SH | | SOLE | | 52,525 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 16,926 | 110,693 | SH | | SOLE | | 110,693 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 5,375 | 9,925 | SH | | SOLE | | 9,925 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 3,174 | 169,930 | SH | | SOLE | | 169,930 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 18,783 | 163,645 | SH | | SOLE | | 163,645 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 21,871 | 154,902 | SH | | SOLE | | 154,902 | 0 | 0 |
Amedisys, Inc. | Common | 023436108 | 5,136 | 19,395 | SH | | SOLE | | 19,395 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 103,644 | 416,560 | SH | | SOLE | | 416,560 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 6,142 | 621,659 | SH | | SOLE | | 621,659 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 59,147 | 164,777 | SH | | SOLE | | 164,777 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 6,545 | 152,538 | SH | | SOLE | | 152,538 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 118 | 32,461 | SH | | SOLE | | 32,461 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 3,808 | 131,633 | SH | | SOLE | | 131,633 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 4,023 | 607,698 | SH | | SOLE | | 607,698 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 13,627 | 196,385 | SH | | SOLE | | 196,385 | 0 | 0 |
Argenx SE | Sponsored ADR | 04016X101 | 17,720 | 64,344 | SH | | SOLE | | 64,344 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 8,812 | 132,886 | SH | | SOLE | | 132,886 | 0 | 0 |
Arvinas, Inc. | Common | 04335A105 | 5,684 | 85,997 | SH | | SOLE | | 85,997 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 15,251 | 118,336 | SH | | SOLE | | 118,336 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C106 | 1,121 | 1,642,302 | SH | | SOLE | | 1,642,302 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 17,120 | 344,333 | SH | | SOLE | | 344,333 | 0 | 0 |
Atreca, Inc. | Class A Common | 04965G109 | 5,403 | 352,424 | SH | | SOLE | | 352,424 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 5,167 | 397,920 | SH | | SOLE | | 397,920 | 0 | 0 |
Becton, Dickinson and Co. | Common | 075887109 | 10,530 | 43,307 | SH | | SOLE | | 43,307 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 14,059 | 40,389 | SH | | SOLE | | 40,389 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 23 | 6,000 | SH | | SOLE | | 6,000 | 0 | 0 |
Bio-Techne Corp. | Common | 09073M104 | 2,903 | 7,600 | SH | | SOLE | | 7,600 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 69,055 | 246,844 | SH | | SOLE | | 246,844 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 9,666 | 128,004 | SH | | SOLE | | 128,004 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 7,514 | 68,814 | SH | | SOLE | | 68,814 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 3,202 | 131,990 | SH | | SOLE | | 131,990 | 0 | 0 |
Blueprint Medicines Corp. | Common | 09627Y109 | 11,930 | 122,699 | SH | | SOLE | | 122,699 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 7,186 | 185,931 | SH | | SOLE | | 185,931 | 0 | 0 |
BridgeBio Pharma, Inc. | Common | 10806X102 | 4,602 | 74,714 | SH | | SOLE | | 74,714 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 56,341 | 892,453 | SH | | SOLE | | 892,453 | 0 | 0 |
Catalent, Inc. | Common | 148806102 | 8,427 | 80,025 | SH | | SOLE | | 80,025 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 145 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis | Sponsored ADR | 15117K103 | 242 | 11,955 | SH | | SOLE | | 11,955 | 0 | 0 |
Centene Corp. | Common | 15135B101 | 4,301 | 67,290 | SH | | SOLE | | 67,290 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 12,484 | 43,074 | SH | | SOLE | | 43,074 | 0 | 0 |
ChemoCentryx, Inc. | Common | 16383L106 | 7,401 | 144,447 | SH | | SOLE | | 144,447 | 0 | 0 |
Cigna Corp. | Common | 125523100 | 45,912 | 189,921 | SH | | SOLE | | 189,921 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 408 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Cogent Biosciences, Inc. | Common | 19240Q201 | 4,721 | 537,742 | SH | | SOLE | | 537,742 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 1,589 | 117,535 | SH | | SOLE | | 117,535 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 687 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 815 | 413,481 | SH | | SOLE | | 413,481 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 18,394 | 150,958 | SH | | SOLE | | 150,958 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 16,550 | 219,995 | SH | | SOLE | | 219,995 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 400 | 88,102 | SH | | SOLE | | 88,102 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 43,044 | 191,240 | SH | | SOLE | | 191,240 | 0 | 0 |
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 13,797 | 307,703 | SH | | SOLE | | 307,703 | 0 | 0 |
Denali Therapeutics Inc. | Common | 24823R105 | 8,570 | 150,086 | SH | | SOLE | | 150,086 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 22,425 | 351,427 | SH | | SOLE | | 351,427 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 26,826 | 74,643 | SH | | SOLE | | 74,643 | 0 | 0 |
Dicerna Pharmaceuticals, Inc. | Common | 253031108 | 1,743 | 68,150 | SH | | SOLE | | 68,150 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 1,710 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 638 | 15,190 | SH | | SOLE | | 15,190 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 19,969 | 238,755 | SH | | SOLE | | 238,755 | 0 | 0 |
Eli Lilly and Co. | Common | 532457108 | 54,573 | 292,114 | SH | | SOLE | | 292,114 | 0 | 0 |
Endo International plc | Shares | G30401106 | 3,939 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Exact Sciences Corp. | Common | 30063P105 | 22,047 | 167,302 | SH | | SOLE | | 167,302 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 24,870 | 1,100,920 | SH | | SOLE | | 1,100,920 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 12,396 | 150,343 | SH | | SOLE | | 150,343 | 0 | 0 |
Five Star Senior Living Inc. | Common | 33832D205 | 148 | 24,237 | SH | | SOLE | | 24,237 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | Shares | 34633R104 | 4,198 | 149,825 | SH | | SOLE | | 149,825 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 9,426 | 391,754 | SH | | SOLE | | 391,754 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 9,189 | 1,041,845 | SH | | SOLE | | 1,041,845 | 0 | 0 |
Gamida Cell Ltd. | Shares | M47364100 | 956 | 118,142 | SH | | SOLE | | 118,142 | 0 | 0 |
Genmab A/S | Sponsored ADS | 372303206 | 2,397 | 73,015 | SH | | SOLE | | 73,015 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 117,362 | 1,815,906 | SH | | SOLE | | 1,815,906 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 2,293 | 174,897 | SH | | SOLE | | 174,897 | 0 | 0 |
Grifols, S.A. | Sponsored ADR | 398438408 | 819 | 47,373 | SH | | SOLE | | 47,373 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 24,230 | 158,727 | SH | | SOLE | | 158,727 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 28,797 | 152,897 | SH | | SOLE | | 152,897 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 1,174 | 10,055 | SH | | SOLE | | 10,055 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 421946104 | 3,154 | 104,024 | SH | | SOLE | | 104,024 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,949 | 70,662 | SH | | SOLE | | 70,662 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 4,773 | 150,392 | SH | | SOLE | | 150,392 | 0 | 0 |
Helix Acquisition Corp. | Class A Common | G4444C102 | 2,559 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 2,126 | 131,183 | SH | | SOLE | | 131,183 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 2,422 | 32,564 | SH | | SOLE | | 32,564 | 0 | 0 |
Horizon Therapeutics plc | Shares | G46188101 | 74,638 | 810,932 | SH | | SOLE | | 810,932 | 0 | 0 |
Humana Inc. | Common | 444859102 | 15,655 | 37,341 | SH | | SOLE | | 37,341 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 8,089 | 166,896 | SH | | SOLE | | 166,896 | 0 | 0 |
Icon plc | Shares | G4705A100 | 4,633 | 23,592 | SH | | SOLE | | 23,592 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 17,035 | 34,814 | SH | | SOLE | | 34,814 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 94,783 | 246,793 | SH | | SOLE | | 246,793 | 0 | 0 |
Incyte Corp. | Common | 45337C102 | 8,752 | 107,687 | SH | | SOLE | | 107,687 | 0 | 0 |
Insmed Inc. | Common | 457669307 | 3,351 | 98,387 | SH | | SOLE | | 98,387 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 4,268 | 53,180 | SH | | SOLE | | 53,180 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 1,779 | 77,067 | SH | | SOLE | | 77,067 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 7,888 | 232,476 | SH | | SOLE | | 232,476 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 15,736 | 21,296 | SH | | SOLE | | 21,296 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 9,728 | 216,371 | SH | | SOLE | | 216,371 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 16,482 | 520,595 | SH | | SOLE | | 520,595 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 13,494 | 69,866 | SH | | SOLE | | 69,866 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 11,088 | 67,456 | SH | | SOLE | | 67,456 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 99,409 | 604,864 | SH | | SOLE | | 604,864 | 0 | 0 |
Jounce Therapeutics, Inc. | Common | 481116101 | 3,926 | 382,237 | SH | | SOLE | | 382,237 | 0 | 0 |
KalVista Pharmaceuticals, Inc. | Common | 483497103 | 1,285 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 10,248 | 85,236 | SH | | SOLE | | 85,236 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 3,247 | 56,927 | SH | | SOLE | | 56,927 | 0 | 0 |
Kura Oncology, Inc. | Common | 50127T109 | 7,731 | 273,463 | SH | | SOLE | | 273,463 | 0 | 0 |
Laboratory Corp. of America Holdings | Sponsored ADR | 50540R409 | 25,396 | 99,580 | SH | | SOLE | | 99,580 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 7,605 | 182,293 | SH | | SOLE | | 182,293 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,560 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 24,565 | 125,948 | SH | | SOLE | | 125,948 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 8,762 | 411,743 | SH | | SOLE | | 411,743 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 3,096 | 18,871 | SH | | SOLE | | 18,871 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 58,145 | 492,214 | SH | | SOLE | | 492,214 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 41,760 | 541,703 | SH | | SOLE | | 541,703 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 3,361 | 997,290 | SH | | SOLE | | 997,290 | 0 | 0 |
Mettler-Toledo International Inc. | Common | 592688105 | 11,326 | 9,800 | SH | | SOLE | | 9,800 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 14,352 | 83,784 | SH | | SOLE | | 83,784 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 61,848 | 472,302 | SH | | SOLE | | 472,302 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 2,517 | 199,420 | SH | | SOLE | | 199,420 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 9,296 | 39,769 | SH | | SOLE | | 39,769 | 0 | 0 |
Morphic Holding, Inc. | Common | 61775R105 | 5,667 | 89,559 | SH | | SOLE | | 89,559 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 1,785 | 81,867 | SH | | SOLE | | 81,867 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 726 | 10,038 | SH | | SOLE | | 10,038 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 3,609 | 180,438 | SH | | SOLE | | 180,438 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 20,704 | 212,891 | SH | | SOLE | | 212,891 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 1,597 | 256,398 | SH | | SOLE | | 256,398 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 954 | 28,988 | SH | | SOLE | | 28,988 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 11,645 | 136,225 | SH | | SOLE | | 136,225 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 19,069 | 105,176 | SH | | SOLE | | 105,176 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 3,264 | 48,406 | SH | | SOLE | | 48,406 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 11,225 | 306,433 | SH | | SOLE | | 306,433 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 1,498 | 372,733 | SH | | SOLE | | 372,733 | 0 | 0 |
Owens & Minor, Inc. | Common | 690732102 | 10,000 | 266,023 | SH | | SOLE | | 266,023 | 0 | 0 |
PerkinElmer, Inc. | Common | 714046109 | 4,759 | 37,094 | SH | | SOLE | | 37,094 | 0 | 0 |
Perrigo Co. plc | Shares | G97822103 | 2,073 | 51,224 | SH | | SOLE | | 51,224 | 0 | 0 |
Personalis, Inc. | Common | 71535D106 | 4,423 | 179,731 | SH | | SOLE | | 179,731 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 25,552 | 705,259 | SH | | SOLE | | 705,259 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 8,760 | 495,733 | SH | | SOLE | | 495,733 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 2,630 | 1,023,348 | SH | | SOLE | | 1,023,348 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 15,938 | 103,943 | SH | | SOLE | | 103,943 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 2,457 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 652 | 63,001 | SH | | SOLE | | 63,001 | 0 | 0 |
R1 RCM Inc. | Common | 749397105 | 3,047 | 123,461 | SH | | SOLE | | 123,461 | 0 | 0 |
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 3,810 | 38,219 | SH | | SOLE | | 38,219 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 72,629 | 153,505 | SH | | SOLE | | 153,505 | 0 | 0 |
REGENXBIO Inc. | Common | 75901B107 | 740 | 21,700 | SH | | SOLE | | 21,700 | 0 | 0 |
Replimune Group, Inc. | Common | 76029N106 | 6,684 | 219,060 | SH | | SOLE | | 219,060 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 25,677 | 132,344 | SH | | SOLE | | 132,344 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 8,865 | 510,660 | SH | | SOLE | | 510,660 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 8,542 | 114,119 | SH | | SOLE | | 114,119 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 4,034 | 81,554 | SH | | SOLE | | 81,554 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 9,613 | 128,987 | SH | | SOLE | | 128,987 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 2,425 | 47,869 | SH | | SOLE | | 47,869 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 31,312 | 225,490 | SH | | SOLE | | 225,490 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 3,773 | 99,560 | SH | | SOLE | | 99,560 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 374 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 24,149 | 126,779 | SH | | SOLE | | 126,779 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 36,983 | 151,830 | SH | | SOLE | | 151,830 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 13,060 | 573,823 | SH | | SOLE | | 573,823 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 20,680 | 272,647 | SH | | SOLE | | 272,647 | 0 | 0 |
Takeda Pharmaceutical Co. Ltd. | Sponsored ADS | 874060205 | 3,837 | 210,146 | SH | | SOLE | | 210,146 | 0 | 0 |
TCR2 Therapeutics Inc. | Common | 87808K106 | 5,207 | 235,808 | SH | | SOLE | | 235,808 | 0 | 0 |
Teladoc Health, Inc. | Common | 87918A105 | 5,391 | 29,664 | SH | | SOLE | | 29,664 | 0 | 0 |
Teleflex Inc. | Common | 879369106 | 914 | 2,200 | SH | | SOLE | | 2,200 | 0 | 0 |
Tenet Healthcare Corp. | Common | 88033G407 | 3,137 | 60,336 | SH | | SOLE | | 60,336 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 881CVR013 | 9 | 42,965 | SH | | SOLE | | 42,965 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 7,623 | 660,551 | SH | | SOLE | | 660,551 | 0 | 0 |
Theravance Biopharma, Inc. | Common | G8807B106 | 9,313 | 456,296 | SH | | SOLE | | 456,296 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 51,869 | 113,653 | SH | | SOLE | | 113,653 | 0 | 0 |
Travere Therapeutics, Inc. | Common | 89422G107 | 5,315 | 212,869 | SH | | SOLE | | 212,869 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 5,684 | 529,226 | SH | | SOLE | | 529,226 | 0 | 0 |
Turning Point Therapeutics, Inc. | Common | 90041T108 | 11,287 | 119,324 | SH | | SOLE | | 119,324 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 11,099 | 97,480 | SH | | SOLE | | 97,480 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 4,211 | 125,003 | SH | | SOLE | | 125,003 | 0 | 0 |
United Therapeutics Corp. | Class B | 91307C102 | 10,624 | 63,513 | SH | | SOLE | | 63,513 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 78,985 | 212,285 | SH | | SOLE | | 212,285 | 0 | 0 |
Universal Health Realty Income Trust | Shares | 91359E105 | 763 | 11,258 | SH | | SOLE | | 11,258 | 0 | 0 |
Universal Health Services, Inc. | Class B | 913903100 | 9,514 | 71,323 | SH | | SOLE | | 71,323 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 11,100 | 208,108 | SH | | SOLE | | 208,108 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 6,286 | 751,905 | SH | | SOLE | | 751,905 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 84,943 | 395,288 | SH | | SOLE | | 395,288 | 0 | 0 |
Vir Biotechnology, Inc. | Common | 92764N102 | 4,173 | 81,400 | SH | | SOLE | | 81,400 | 0 | 0 |
VYNE Therapeutics Inc. | Common | 92941V209 | 927 | 135,395 | SH | | SOLE | | 135,395 | 0 | 0 |
Waters Corp. | Common | 941848103 | 29,187 | 102,710 | SH | | SOLE | | 102,710 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 14,547 | 203,083 | SH | | SOLE | | 203,083 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 2,970 | 165,898 | SH | | SOLE | | 165,898 | 0 | 0 |
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 5,982 | 197,820 | SH | | SOLE | | 197,820 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 5,007 | 37,523 | SH | | SOLE | | 37,523 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 33,267 | 207,814 | SH | | SOLE | | 207,814 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 8,901 | 56,521 | SH | | SOLE | | 56,521 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 1,737 | 88,977 | SH | | SOLE | | 88,977 | 0 | 0 |